SURFACE ONCOLOGY, INC.: cashflow_financing
| Value | {"amount": 40082000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | SURFACE ONCOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c00f218c-166d-4067-b664-fa5034ac42b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001718108-21-000013Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001718108/cashflow-financing/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c00f218c-166d-4067-b664-fa5034ac42b1
History
- no predecessors — first report